| アブストラクト | BACKGROUND: Restrictions implemented by governments during the coronavirus disease 2019 (COVID-19) pandemic affected people's eating habits and physical activity. We investigated the effect of COVID-19 lockdowns and restrictions on body mass index (BMI) and weight in a UK population, according to BMI class, sex, age and ethnicity. METHODS: This retrospective observational cohort study used the Clinical Practice Research Datalink AURUM database. Baseline spanned from 22 March 2017-22 March 2020, and the follow-up lockdown period was from 23 March 2020 (start of the lockdown in the UK) to 13 March 2021. The descriptive analysis included individuals with >/= 1 valid BMI/weight measurements during both the baseline and follow-up periods, while the model-based analysis comprised individuals with >/= 1 valid measurement(s) during baseline. Results were stratified by baseline BMI category, sex, age and ethnicity. RESULTS: In the descriptive analysis (n = 273,529), most individuals did not change BMI category post-lockdown (66.4-83.3%). A greater proportion of women (12.6%) than men (9.5%) moved up BMI categories post-lockdown. Compared with older groups, a higher proportion of individuals < 45 years old increased post-lockdown BMI category. The model-based analysis (n = 938,150) revealed consistent trends, where changes in body weight and BMI trajectories pre- and post-lockdown were observed for women and for individuals < 45 years. CONCLUSION: During COVID-19 restrictions, women and young individuals were more likely than other groups to increase BMI category and weight post-lockdown. |
|---|
| ジャーナル名 | Obesity research & clinical practice |
|---|
| Pubmed追加日 | 2023/10/3 |
|---|
| 投稿者 | Zaccardi, Francesco; Byrne, Katherine; Khunti, Kamlesh; Kloecker, David; Reynoso, Ricardo; Shabnam, Sharmin; Vaz, Luis; Yates, Thomas; Gillies, Clare |
|---|
| 組織名 | Diabetes Research Centre, Leicester General Hospital, University of Leicester,;Leicester, UK; Leicester Real World Evidence Unit, Diabetes Research Centre,;University of Leicester, Leicester, UK. Electronic address: fz43@leicester.ac.uk.;Novo Nordisk Health Care AG, Zurich, Switzerland.;University of Leicester, Leicester, UK; National Institute for Health Research;Applied Research Collaboration East Midlands, Leicester Diabetes Centre,;Leicester, UK; National Institute for Health Research Leicester Biomedical;Research Centre, University of Leicester and University Hospitals of Leicester;NHS Trust, Leicester, UK.;University of Leicester, Leicester, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/37783586/ |
|---|
